Effects of scopolamine challenge on regional cerebral blood volume. A pharmacological model to validate the use of contrast enhanced magnetic resonance imaging to assess cerebral blood volume in a canine model of aging

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 3, 2005, Pages 399-406

  Tapp, P Dwight ^a   Chu, Yong ^a   Araujo, Joseph A ^b   Chiou Jr , Yuan ^c   Head, Elizabeth ^a   Milgram, Norton W ^b   Su, Min Ying ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aging; Blood volume; Dog; Dynamic contrast; Magnetic imaging; Scopolamine

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

AGE DISTRIBUTION; AGING; ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD VOLUME; COGNITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAY MATTER; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL SIGNIFICANCE; WHITE MATTER;

EID: 15744406038     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.12.006     Document Type: Article

References (76)

1. B. Adams, A. Chan, H. Callahan, and N.W. Milgram The canine as a model of human cognitive aging: recent developments Prog. Neuro-psychopharmacol. Biol. Psychiatry 24 5 2000 675 692
2. B. Adams, A. Chan, H. Callahan, C. Siwak, D. Tapp, C. Ikeda-Douglas, P. Atkinson, E. Head, C.W. Cotman, and N.W. Milgram Use of a delayed non-matching to position task to model age-dependent cognitive decline in the dog Behav. Brain Res. 108 1 2000 47 56
3. R.S. Ajmani, E.J. Metter, R. Jaykumar, D.K. Ingram, E.L. Spangler, O.O. Abugo, and J.M. Rifkind Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function Neurobiol. Aging 21 2 2000 257 269
4. J.S. Andrews, J.H. Jansen, S. Linders, and A. Princen Effects of disrupting the cholinergic system on short-term spatial memory in rats Psychopharmacology 115 1994 485 494
5. J.A. Araujo, A.D. Chan, L.L. Winka, P.A. Seymour, and N.W. Milgram Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination Psychopharmacology 175 2004 92 98
6. R.T. Bartus, and H.R. Johnson Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine Pharmacol. Biochem. Behav. 5 1976 39 46
7. A. Bozzao, R. Floris, M.E. Baviera, A. Apruzzese, and G. Simonetti Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load Am. J. Neuroradiol. 22 6 2001 1030 1036
8. A.D. Chan, P.M. Nippak, H. Murphey, C.J. Ikeda-Douglas, B. Muggenburg, E. Head, C.W. Cotman, and N.W. Milgram Visuospatial impairments in aged canines (Canis familiaris): the role of cognitive-behavioral flexibility Behav. Neurosci. 116 3 2002 443 454
9. J.G. Crawford Alzheimer's disease risk factors as related to cerebral blood flow Med. Hypotheses 46 4 1996 367 377
10. J.G. Crawford Alzheimer's disease risk factors as related to cerebral blood flow: additional evidence Med. Hypotheses 50 1 1998 25 36
11. B.J. Cummings, E. Head, A.J. Afagh, N.W. Milgram, and C.W. Cotman Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine Neurobiol. Learn. Mem. 66 1 1996 11 23
12. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimers disease Lancet 2 1976 1403
13. D.A. Drachman, and J. Leavitt Human memory and the cholinergic system. A relationship to aging? Arch. Neurol. 30 1974 113 121
14. M. Encinas, R. De Juan, A. Marcos, P. Gil, A. Barabash, C. Fernandez, C. De Ugarte, and J.A. Cabranes Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease Eur. J. Nucl. Med. Mol. Imaging 30 11 2003 1473 1480
15. C. Estrada, E. Hamel, and D.N. Krause Biochemical evidence for cholinergic innervation of intracerebral blood vessels Brain Res. 266 1983 261 270
16. E. Farkas, and P.G. Luiten Cerebral microvascular pathology in aging and Alzheimer's disease Prog. Neurobiol. 64 6 2001 575 611
17. C. Flicker, S.H. Ferris, and M. Serby Hypersensitivity to scopolamine in the elderly Psychopharmacology 107 1992 437 441
18. H. Fukuyama, Y. Ouchi, S. Matsuzaki, M. Ogawa, H. Yamauchi, Y. Nagahama, J. Kimura, Y. Yonekura, H. Shibasaki, and H. Tsukada Focal cortical blood flow activation is regulated by intrinsic cortical cholinergic neurons NeuroImage 3 1996 195 201
19. D.R. Gitelman, and I. Prohovnik Muscarinic and nicotinic contributions to cognitive function and cortical blood flow Neurobiol. Aging 13 2 1992 313 318
20. S.D. Glick, and M.E. Jarvik Amphetamine, scopolamine, and chlorpromazine interactions on delayed matching performance in monkeys Psychopharmacologia 16 1969 147 155
21. S.D. Glick, and M.E. Jarvik Differential effects of amphetamine and scopolamine upon matching performance of monkeys with lateral frontal lesions J. Comp. Physiol. Psychol. 73 1970 307 313
22. J. González-Soriano, M.P. García, J. Contreras- Rodríguez, P. Martínez-Sainz, and E. Rodríguez-Veiga Age-related changes in the ventricular system of the dog brain Ann. Anat. 183 3 2001 283 291
23. G.J. Harris, J.M. Links, G.D. Pearlson, and E.E. Camargo Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease Psychiatry Res. 40 3 1991 167 180
24. G.J. Harris, R.F. Lewis, A. Satlin, C.D. English, T.M. Scott, D.A. Yurgelun-Todd, and P.F. Renshaw Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine Am. J. Neuroradiol. 19 9 1998 1727 1732
25. E. Head, and R. Torp Insights into Abeta and presenilin from a canine model of human brain aging Neurobiol. Dis. 9 1 2002 1 10
26. E. Head, R. Mehta, J. Hartley, M. Kameka, B.J. Cummings, C.W. Cotman, W.W. Ruehl, and N.W. Milgram Spatial learning and memory as a function of age in the dog Behav. Neurosci. 109 5 1995 851 858
27. E. Head, H. Callahan, B.A. Muggenburg, C.W. Cotman, and N.W. Milgram Visual-discrimination learning ability and beta-amyloid accumulation in the dog Neurobiol. Aging 19 5 1998 415 425
28. E. Head, C.W. Cotman, and N.W. Milgram Canine cognition, aging and neuropathology Prog. Neuro-psychopharmacol. Biol. Psychiatry 24 5 2000 671 673
29. E. Head, R. McCleary, F.F. Hahn, N.W. Milgram, and C.W. Cotman Region-specific age at onset of beta-amyloid in dogs Neurobiol. Aging 21 1 2000 89 96
30. E. Head, J. Liu, T.M. Hagen, B.A. Muggenburg, N.W. Milgram, B.N. Ames, and C.W. Cotman Oxidative damage increases with age in a canine model of human brain aging J. Neurochem. 82 2 2002 375 381
31. J. Helenius, J. Perkio, L. Sionne, L. Østergaard, R.A.D. Carano, O. Salonen, S. Savolainen, M. Kaste, H.J. Arnonen, and T. Tatlisumak Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging Acta Radiol. 44 2003 538 546
32. W.G. Honer, I. Prohovnik, G. Smith, and L.R. Lucas Scopolamine reduces frontal cortex perfusion J. Cereb. Blood Flow Metab. 8 5 1988 635 641
33. Y. Koshimoto, H. Yamada, H. Kimura, M. Maeda, C. Tsuchida, Y. Kawamura, and Y. Ishii Quantitative analysis of cerebral microvascular hemodynamics with T2-weighted dynamic MR imaging J. Magn. Reson. Imaging 9 3 1999 462 467
34. J.J. Kril, and G.M. Halliday Alzheimer's disease: its diagnosis and pathogenesis Int. Rev. Neurobiol. 48 2001 167 217
35. L. Li, Y. Chu, A.F. Salem, and R.A. Clark Image Segmentation and 3D Visualization for MRI Mammography Proc. SPIE Med. Imaging 4684 2002 1780 1789
36. W. Lojkowska, D. Ryglewicz, T. Jedrzejczak, S. Minc, T. Jakubowska, H. Jarosz, and A. Bochynska The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia J. Neurol. Sci. 216 1 2003 119 126
37. E.D. London, M. Ohata, H. Takei, A.W. French, and S.I. Rapoport Regional cerebral metabolic rate for glucose in beagle dogs of different ages Neurobiol. Aging 4 2 1983 121 126
38. K.S. Milar, and L.A. Dykstra The effects of morphine and scopolamine on auditory discrimination in squirrel monkeys Psychopharmacology 85 1985 148 150
39. N.W. Milgram, E. Head, E. Weiner, and E. Thomas Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks Behav. Neurosci. 108 1 1994 57 68
40. S.E. Molchan, R.A. Martinez, J.L. Hill, H.J. Weingartner, K. Thompson, B. Vitiello, and T. Sunderland Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model Brain Res. Brain Res. Rev. 17 1992 215 226
41. Y. Nagahama, H. Nabatame, T. Okina, H. Yamauchi, M. Narita, N. Fujimoto, M. Murakami, H. Fukuyama, and M. Matsuda Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease Eur. Neurol. 50 1 2003 1 9
42. J.A. Nelder, and R. Mead A simplex method for function minimization Comput. J. 7 1965 308 313
43. L. Østergaard, R. Weisskoff, D. Chesler, C. Gyldensted, and B.R. Rosen High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis Magn. Reson. Med. 36 5 1996 715 725
44. G.D. Pearlson, G.J. Harris, R.E. Powers, P.E. Barta, E.E. Camargo, G.A. Chase, J.T. Noga, and L.E. Tune Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease Arch. Gen. Psychiatry 49 5 1992 402 408
45. E.K. Perry The cholinergic hypothesis-ten years on Br. Med. Bull. 42 1986 63 69
46. E. Perry Acetylcholine and Alzheimer's disease Br. J. Psychiatry 152 1988 737 740
47. E.K. Perry, R.H. Perry, G. Blessed, and B.E. Tomlinson Necropsy evidence of central cholinergic deficits in senile dementia Lancet 1 1977 189
48. E.K. Perry, B.E. Tomlinson, G. Blessed, K. Bergmann, P.H. Gibson, and R.H. Perry Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia Br. Med. J. 2 1978 1457 1459
49. J.J. Pilcher, G.R. Sessions, and S.A. McBride Scopolamine impairs spatial working memory in the radial maze: an analysis by error type and arm choice Pharmacol. Biochem. Behav. 58 1997 449 459
50. I. Prohovnik, S.E. Arnold, G. Smith, and L.R. Lucas Physostigmine reversal of scopolamine-induced hypofrontality J. Cereb. Blood Flow Metab. 17 2 1997 220 228
51. N. Ravel, M. Vigouroux, A. Elaagouby, and R. Gervais Scopolamine impairs delayed matching in an olfactory task in rats Psychopharmacology 109 1992 439 443
52. B.R. Reed, W.J. Jagust, J.P. Saeb, and B.A. Ober Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease Neurology 39 1989 1537 1539
53. A. Sato, and Y. Sato Cholinergic neural regulation cerebral blood flow Alzheimer Dis. 9 1 1995 28 38
54. T. Satou, B.J. Cummings, E. Head, K.A. Nielson, F.F. Hahn, N.W. Milgram, P. Velazquez, D.H. Cribbs, A.J. Tenner, and C.W. Cotman The progression of beta-amyloid deposition in the frontal cortex of the aged canine Brain Res. 774 1-2 1997 35 43
55. C.T. Siwak, P.D. Tapp, and N.W. Milgram Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the beagle dog Learn. Mem. 8 6 2001 317 325
56. C.T. Siwak, H.L. Murphey, B.A. Muggenburg, and N.W. Milgram Age-dependent decline in locomotor activity in dogs is environment specific Physiol. Behav. 75 1-2 2002 65 70
57. C.T. Siwak, P.D. Tapp, S.C. Zicker, H.L. Murphey, B.A. Muggenburg, E. Head, C.W. Cotman, and N.W. Milgram Locomotor activity rhythms in dogs vary with age and cognitive status Behav. Neurosci. 117 4 2003 813 824
58. I. Skoog, R.N. Kalaria, and M.M. Breteler Vascular factors and Alzheimer disease Alzheimer Dis. Assoc. Disord., Suppl. 3 1999 S106 S114
59. M.Y. Su, E. Head, W.M. Brooks, Z. Wang, B.A. Muggenburg, G.E. Adam, R. Sutherland, C.W. Cotman, and O. Nalcioglu Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging Neurobiol. Aging 19 5 1998 479 485
60. H. Tabata, H. Holloway, W.R. Fredericks, A.W. French, and S.I. Rapoport Regional cerebral blood flow in awake beagles of different ages Brain 4 1986 771 784
61. P.D. Tapp, C.T. Siwak, J. Estrada, E. Head, B.A. Muggenburg, C.W. Cotman, and N.W. Milgram Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging Learn. Mem. 10 1 2003 64 73
62. P.D. Tapp, C.T. Siwak, J. Estrada, D. Holowachuk, and N.W. Milgram Effects of age on measures of complex working memory span in the beagle dog (Canis familiaris) using two versions of a spatial list learning paradigm Learn. Mem. 10 2 2003 148 160
63. P.D. Tapp, C.T. Siwak, E. Head, C.W. Cotman, H. Murphey, B.A. Muggenburg, C. Ikeda-Douglas, and N.W. Milgram Concept abstraction in the aging dog: development of a protocol using successive discrimination and size concept tasks Behav. Brain Res. 153 1 2004 199 210
64. P.D. Tapp, C.T. Siwak, F.-Q. Gao, J.-Y. Chiou, S.E. Black, E. Head, B.A. Muggenburg, C.W. Cotman, N.W. Milgram, and M.-Y. Su Frontal lobe volume, function, and Aβ pathology in a canine model of aging J. Neurosci. 24 38 2004 8205 8213
65. P.N. Tariot, S.V. Patel, C. Cox, and R.E. Henderson Age-related decline in central cholinergic function demonstrated with scopolamine Psychopharmacology 125 1996 50 56
66. R. Torp, E. Head, and C.W. Cotman Ultrastructural analyses of beta-amyloid in the aged dog brain: neuronal beta-amyloid is localized to the plasma membrane Prog. Neuro-psychopharmacol. Biol. Psychiatry 24 5 2000 801 810
67. R. Torp, E. Head, N.W. Milgram, F. Hahn, O.P. Ottersen, and C.W. Cotman Ultrastructural evidence of fibrillar beta-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains Neuroscience 96 3 2000 495 506
68. H. Tsukada, T. Kakiuchi, I. Ando, and Y. Ouchi Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys J. Pharmacol. Exp. Ther. 281 3 1997 1408 1414
69. H. Tsukada, S. Yamazaki, A. Noda, T. Inoue, N. Matsuoka, T. Kakiuchi, S. Nishiyama, and S. Nishimura FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys Brain Res. 832 1-2 1999 118 123
70. A. Tudorica, H. Fang-Li, F. Hospod, E. Delucia-Deranja, W. Huang, C.S. Patlak, and G.C. Newman Cerebral blood volume measurements by rapid contrast infusion and T2*-weighted echo planar MRI Magn. Reson. Med. 47 6 2002 1145 1157
71. C.H. Vite, E.K. Insko, H.M. Schotland, K. Panckeri, and J.C. Hendricks Quantification of cerebral ventricular volume in English bulldogs Vet. Radiol. Ultrasound 38 6 1997 437 443
72. P.J. Whitehouse, D.L. Price, A.W. Clark, J.T. Coyle, and M.R. DeLong Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis Ann. Neurol. 10 1981 122 126
73. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, and M.R. Delon Alzheimers disease and senile dementia: loss of neurons in the basal forebrain Science 215 1982 1237 1239
74. E.X. Wu, H. Tang, T. Asai, and S.D. Yan Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice Neurosci. Lett. 365 3 2004 223 227
75. K.L. Zierler Theoretical basis of indicator-dilution methods for measuring flow and volume Circ. Res. 10 1962 393 407
76. K.L. Zierler Equations for measuring blood flow by external monitoring of radioisotope Circ. Res. 16 1965 309 321